Literature DB >> 17898869

B-FABP-expressing radial glial cells: the malignant glioma cell of origin?

Raja Mita1, Jeffrey E Coles, Darryl D Glubrecht, Rohyun Sung, Xuejun Sun, Roseline Godbout.   

Abstract

Brain fatty acid-binding protein (B-FABP) is normally expressed in radial glial cells, where it plays a role in the establishment of the radial glial fiber network required for neuronal migration. B-FABP is also expressed in astrocytoma tumors and in some malignant glioma cell lines. To address the role of B-FABP in malignant glioma, we have studied the growth properties of clonal populations of malignant glioma cells modified for B-FABP expression. Here, we demonstrate that expression of B-FABP in B-FABP-negative malignant glioma cells is accompanied by the appearance of radial glial-like properties, such as increased migration and extended bipolar cell processes, as well as reduced transformation. Conversely, B-FABP depletion in B-FABP-positive malignant glioma cells results in decreased migration, reduction in cell processes, and a more transformed phenotype. Moreover, expression of B-FABP in astrocytomas is associated with regions of tumor infiltration and recurrence. Rather than being a direct manifestation of the tumorigenic process, we propose that the ability of high-grade astrocytoma cells to migrate long distances from the primary tumor reflects properties associated with their cell of origin. Thus, targeting B-FABP-expressing cells may make a significant impact on the treatment of these tumors.

Entities:  

Keywords:  Astrocytoma; brain fatty acid-binding protein; infiltration; migration; radial glia

Mesh:

Substances:

Year:  2007        PMID: 17898869      PMCID: PMC1993858          DOI: 10.1593/neo.07439

Source DB:  PubMed          Journal:  Neoplasia        ISSN: 1476-5586            Impact factor:   5.715


  53 in total

1.  Radial glia give rise to adult neural stem cells in the subventricular zone.

Authors:  Florian T Merkle; Anthony D Tramontin; José Manuel García-Verdugo; Arturo Alvarez-Buylla
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-01       Impact factor: 11.205

Review 2.  Neural stem cells and the origin of gliomas.

Authors:  Nader Sanai; Arturo Alvarez-Buylla; Mitchel S Berger
Journal:  N Engl J Med       Date:  2005-08-25       Impact factor: 91.245

Review 3.  Biochemistry and biomechanics of cell motility.

Authors:  Song Li; Jun-Lin Guan; Shu Chien
Journal:  Annu Rev Biomed Eng       Date:  2005       Impact factor: 9.590

4.  The tyrosine kinase pyk2 promotes migration and invasion of glioma cells.

Authors:  Christopher A Lipinski; Nhan L Tran; Emmanuel Menashi; Carole Rohl; Jean Kloss; R Curtis Bay; Michael E Berens; Joseph C Loftus
Journal:  Neoplasia       Date:  2005-05       Impact factor: 5.715

5.  Constructing circuits: neurogenesis and migration in the developing neocortex.

Authors:  Arnold R Kriegstein
Journal:  Epilepsia       Date:  2005       Impact factor: 5.864

6.  Hans-Joachim Scherer (1906-1945), pioneer in glioma research.

Authors:  J Peiffer; P Kleihues
Journal:  Brain Pathol       Date:  1999-04       Impact factor: 6.508

7.  Gene expression profiling reveals molecularly and clinically distinct subtypes of glioblastoma multiforme.

Authors:  Yu Liang; Maximilian Diehn; Nathan Watson; Andrew W Bollen; Ken D Aldape; M Kelly Nicholas; Kathleen R Lamborn; Mitchel S Berger; David Botstein; Patrick O Brown; Mark A Israel
Journal:  Proc Natl Acad Sci U S A       Date:  2005-04-12       Impact factor: 11.205

Review 8.  Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas.

Authors:  Hiroko Ohgaki; Paul Kleihues
Journal:  J Neuropathol Exp Neurol       Date:  2005-06       Impact factor: 3.685

Review 9.  The cytoskeleton and brain tumour cell migration.

Authors:  S L Maidment
Journal:  Anticancer Res       Date:  1997 Nov-Dec       Impact factor: 2.480

10.  Liver fatty acid binding protein expression in colorectal neoplasia.

Authors:  L C Lawrie; S R Dundas; S Curran; G I Murray
Journal:  Br J Cancer       Date:  2004-05-17       Impact factor: 7.640

View more
  32 in total

1.  Effects of nuclear factor I phosphorylation on calpastatin (CAST) gene variant expression and subcellular distribution in malignant glioma cells.

Authors:  The Minh Vo; Rebecca Burchett; Miranda Brun; Elizabeth A Monckton; Ho-Yin Poon; Roseline Godbout
Journal:  J Biol Chem       Date:  2018-11-30       Impact factor: 5.157

2.  HIF-1α is critical for hypoxia-mediated maintenance of glioblastoma stem cells by activating Notch signaling pathway.

Authors:  L Qiang; T Wu; H-W Zhang; N Lu; R Hu; Y-J Wang; L Zhao; F-H Chen; X-T Wang; Q-D You; Q-L Guo
Journal:  Cell Death Differ       Date:  2011-08-05       Impact factor: 15.828

Review 3.  Metabolic heterogeneity and adaptability in brain tumors.

Authors:  Christian E Badr; Daniel J Silver; Florian A Siebzehnrubl; Loic P Deleyrolle
Journal:  Cell Mol Life Sci       Date:  2020-06-06       Impact factor: 9.261

4.  Calcineurin regulates nuclear factor I dephosphorylation and activity in malignant glioma cell lines.

Authors:  Miranda Brun; Darryl D Glubrecht; Shairaz Baksh; Roseline Godbout
Journal:  J Biol Chem       Date:  2013-07-09       Impact factor: 5.157

5.  The War on Cancer rages on.

Authors:  Alnawaz Rehemtulla
Journal:  Neoplasia       Date:  2009-12       Impact factor: 5.715

6.  Differential expressions of BMPR1α, ACTN4α and FABP7 in Hirschsprung disease.

Authors:  Weilin Wang; Zhenwei Su; Dong Chen; Jie Mi; Hong Gao
Journal:  Int J Clin Exp Pathol       Date:  2014-04-15

7.  Neoplasia: the second decade.

Authors:  Alnawaz Rehemtulla
Journal:  Neoplasia       Date:  2008-12       Impact factor: 5.715

8.  The influence of feeding linoleic, gamma-linolenic and docosahexaenoic acid rich oils on rat brain tumor fatty acids composition and fatty acid binding protein 7 mRNA expression.

Authors:  Javad Nasrollahzadeh; Fereydoun Siassi; Mahmood Doosti; Mohammad Reza Eshraghian; Fazel Shokri; Mohammad Hossein Modarressi; Javad Mohammadi-Asl; Khosro Abdi; Arash Nikmanesh; Seyed Morteza Karimian
Journal:  Lipids Health Dis       Date:  2008-11-16       Impact factor: 3.876

9.  Molecular properties of CD133+ glioblastoma stem cells derived from treatment-refractory recurrent brain tumors.

Authors:  Qinghai Liu; David H Nguyen; Qinghua Dong; Peter Shitaku; Kenneth Chung; On Ying Liu; Jonathan L Tso; Jason Y Liu; Veerauo Konkankit; Timothy F Cloughesy; Paul S Mischel; Timothy F Lane; Linda M Liau; Stanley F Nelson; Cho-Lea Tso
Journal:  J Neurooncol       Date:  2009-05-26       Impact factor: 4.130

10.  Brain-type and liver-type fatty acid-binding proteins: new tumor markers for renal cancer?

Authors:  Angelika Tölle; Monika Jung; Michael Lein; Manfred Johannsen; Kurt Miller; Holger Moch; Klaus Jung; Glen Kristiansen
Journal:  BMC Cancer       Date:  2009-07-21       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.